<VariationArchive VariationID="3237465" VariationName="NM_017780.4(CHD7):c.5397del (p.Phe1799fs)" VariationType="Deletion" Accession="VCV003237465" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-10" DateCreated="2024-06-10" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3396586" VariationID="3237465">
      <GeneList>
        <Gene Symbol="CHD7" FullName="chromodomain helicase DNA binding protein 7" GeneID="55636" HGNC_ID="HGNC:20626" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>8q12.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="60678740" stop="60868028" display_start="60678740" display_stop="60868028" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="61591323" stop="61780586" display_start="61591323" display_stop="61780586" Strand="+" />
          </Location>
          <OMIM>608892</OMIM>
          <Haploinsufficiency last_evaluated="2023-04-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CHD7">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2023-04-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CHD7">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_017780.4(CHD7):c.5397del (p.Phe1799fs)</Name>
      <CanonicalSPDI>NC_000008.11:60849146:C:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>8q12.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="60849147" stop="60849147" display_start="60849147" display_stop="60849147" variantLength="1" positionVCF="60849146" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="61761706" stop="61761706" display_start="61761706" display_stop="61761706" variantLength="1" positionVCF="61761705" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>F1799fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.10" sequenceAccession="NC_000008" sequenceVersion="10" change="g.61761706del" Assembly="GRCh37">
            <Expression>NC_000008.10:g.61761706del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.11" sequenceAccession="NC_000008" sequenceVersion="11" change="g.60849147del" Assembly="GRCh38">
            <Expression>NC_000008.11:g.60849147del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007009.1" sequenceAccession="NG_007009" sequenceVersion="1" change="g.175368del">
            <Expression>NG_007009.1:g.175368del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_017780.4" sequenceAccession="NM_017780" sequenceVersion="4" change="c.5397del" MANESelect="true">
            <Expression>NM_017780.4:c.5397del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_060250.2" sequenceAccession="NP_060250" sequenceVersion="2" change="p.Phe1799fs">
            <Expression>NP_060250.2:p.Phe1799fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001316690.1" sequenceAccession="NM_001316690" sequenceVersion="1" change="c.1717-13082del">
            <Expression>NM_001316690.1:c.1717-13082del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_176" sequenceAccession="LRG_176">
            <Expression>LRG_176:g.175368del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_176t1" sequenceAccession="LRG_176t1">
            <Expression>LRG_176t1:c.5397del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_176p1" sequenceAccession="LRG_176p1" change="p.Phe1799Leufs">
            <Expression>LRG_176p1:p.Phe1799Leufs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_017780.4(CHD7):c.5397del (p.Phe1799fs) AND Hypogonadotropic hypogonadism 5 with or without anosmia" Accession="RCV004560457" Version="1">
        <ClassifiedConditionList TraitSetID="516">
          <ClassifiedCondition DB="MedGen" ID="C3552553">Hypogonadotropic hypogonadism 5 with or without anosmia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-06-10" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="516" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5355" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hypogonadotropic hypogonadism 5 with or without anosmia</ElementValue>
                <XRef ID="MONDO:0012880" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPOGONADOTROPIC HYPOGONADISM 5 WITH ANOSMIA</ElementValue>
                <XRef Type="Allelic variant" ID="608892.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608892.0013" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPOGONADOTROPHIC HYPOGONADISM 5 WITHOUT ANOSMIA</ElementValue>
                <XRef Type="Allelic variant" ID="608892.0014" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Kallmann syndrome 5</ElementValue>
                <XRef ID="Kallmann+syndrome+5/8704" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HH5</ElementValue>
                <XRef Type="MIM" ID="612370" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">KAL5</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Isolated gonadotropin-releasing hormone (GnRH) deficiency (IGD) is characterized by inappropriately low serum concentrations of the gonadotropins LH (luteinizing hormone) and FSH (follicle-stimulating hormone) in the presence of low circulating concentrations of sex steroids. IGD is associated with a normal sense of smell (normosmic IGD) in approximately 40% of affected individuals and an impaired sense of smell (Kallmann syndrome) in approximately 60%. IGD can first become apparent in infancy, adolescence, or adulthood. Infant boys with congenital IGD often have micropenis and cryptorchidism. Adolescents and adults with IGD have clinical evidence of hypogonadism and incomplete sexual maturation on physical examination. Adult males with IGD tend to have prepubertal testicular volume (i.e., &lt;4 mL), absence of secondary sexual features (e.g., facial and axillary hair growth, deepening of the voice), decreased muscle mass, diminished libido, erectile dysfunction, and infertility. Adult females have little or no breast development and primary amenorrhea. Although skeletal maturation is delayed, the rate of linear growth is usually normal except for the absence of a distinct pubertal growth spurt.</Attribute>
                <XRef ID="NBK1334" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">CHD7-Related GnRH Deficiency (Kallmann Syndrome 5)</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10773" />
                <XRef ID="10773" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">CHD7-Related Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000527475" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556729" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000334133" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556733" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000506067" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558347" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301296</ID>
                <ID Source="BookShelf">NBK1117</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301509</ID>
                <ID Source="BookShelf">NBK1334</ID>
              </Citation>
              <XRef ID="478" DB="Orphanet" />
              <XRef ID="C3552553" DB="MedGen" />
              <XRef ID="MONDO:0012880" DB="MONDO" />
              <XRef Type="MIM" ID="612370" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="9799026" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2024-06-09">
        <ClinVarSubmissionID localKey="NM_017780.4:c.5397del|OMIM:612370" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005049299" DateUpdated="2024-06-09" DateCreated="2024-06-09" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_017780.4:c.5397del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="612370" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>WES_20231129_20240331</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9799026" TraitType="Disease" MappingType="XRef" MappingValue="612370" MappingRef="OMIM">
        <MedGen CUI="C3552553" Name="Hypogonadotropic hypogonadism 5 with or without anosmia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

